Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Ofatumumab in Relapsed/Refractory NHL
NCT01060384Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Mar 2010
- Primary completion
- Oct 2016
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, ofatumumab in non-Hodgkin lymphoma (NHL), sponsored by University of Nebraska. Started Mar 2010; status: completed.
02
Drugs
lenalidomideofatumumab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01060384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060384.